メタ情報
| meta description平均長 | 152.09 |
|---|
| OGPありページ数 | 12 |
|---|
| Twitterカードありページ数 | 12 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 15 |
|---|
| ページあたり内部リンク平均 | 5.33 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| leadership | 1 |
| Chief | 0.832112 |
| Officer | 0.832112 |
| career | 0.762769 |
| University | 0.693426 |
| assays | 0.65 |
| serves | 0.624084 |
| bringing | 0.624084 |
| Cell | 0.521175 |
| business | 0.502909 |
| AAV | 0.5 |
| his | 0.485398 |
| senior | 0.485398 |
| roles | 0.485398 |
| She | 0.485398 |
| where | 0.485398 |
| site | 0.464223 |
| compliance | 0.45 |
| CDMO | 0.439748 |
| process | 0.425538 |
| studies | 0.425538 |
| strategy | 0.425538 |
| plasmids | 0.425538 |
| leads | 0.416056 |
| growth | 0.416056 |
| her | 0.416056 |
| held | 0.416056 |
| positions | 0.416056 |
| Earlier | 0.416056 |
| holds | 0.416056 |
| integrated | 0.415317 |
| ICH | 0.4 |
| strategic | 0.4 |
| TESSA | 0.4 |
| vector | 0.398546 |
| operations | 0.367888 |
| modalities | 0.35 |
| ensuring | 0.35 |
| safety | 0.348168 |
| Cloak | 0.346713 |
| driving | 0.346713 |
| served | 0.346713 |
| Manwani | 0.346713 |
| experience | 0.339442 |
| life | 0.337231 |
| viral | 0.330902 |
| advanced | 0.328825 |
| partner | 0.328825 |
| Services | 0.309482 |
| patient | 0.309482 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Advanced | Therapies | 4.502293 | 229 |
| Advanced | Minaris | 3.78394 | 245 |
| Follow | LinkedIn | 3.526191 | 48 |
| LinkedIn | stay | 3.526191 | 48 |
| stay | updated | 3.526191 | 48 |
| innovations | insights | 3.460614 | 48 |
| intro | section | 3.455466 | 44 |
| does | section | 3.455466 | 44 |
| Whether | you | 3.426421 | 60 |
| does | not | 3.324006 | 44 |
| commitment | reach | 3.318523 | 44 |
| cell | gene | 3.29048 | 165 |
| early | stage | 3.289189 | 68 |
| allogeneic | autologous | 3.260101 | 38 |
| exist | not | 3.255535 | 44 |
| company | news | 3.250529 | 48 |
| ideal | make | 3.168569 | 40 |
| company | innovations | 3.067714 | 48 |
| innovations | news | 3.038602 | 36 |
| Chief | serves | 3.024502 | 35 |
| industry | updated | 2.993184 | 48 |
| helping | innovators | 2.987009 | 40 |
| tech | transfer | 2.984218 | 52 |
| Asia | Europe | 2.976078 | 31 |
| Whether | succeed | 2.935068 | 40 |
| dedicated | helping | 2.935068 | 40 |
| gene | therapy | 2.934764 | 122 |
| industry | insights | 2.927607 | 48 |
| Follow | stay | 2.878668 | 36 |
| LinkedIn | updated | 2.878668 | 36 |
| cell | therapy | 2.840878 | 151 |
| Follow | biologics | 2.840839 | 40 |
| does | intro | 2.823399 | 33 |
| insights | updated | 2.821299 | 36 |
| America | North | 2.803005 | 20 |
| does | exist | 2.763529 | 33 |
| Minaris | Therapies | 2.763005 | 166 |
| commitment | make | 2.762687 | 34 |
| Chief | Officer | 2.762687 | 34 |
| more | than | 2.718734 | 36 |
| ideal | partner | 2.712238 | 40 |
| not | section | 2.708455 | 33 |
| launch | preparing | 2.57931 | 30 |
| over | years | 2.560908 | 35 |
| EMA | FDA | 2.508944 | 16 |
| long | term | 2.508944 | 16 |
| America | Europe | 2.427895 | 20 |
| Vector | Viral | 2.420628 | 16 |
| company | insights | 2.420205 | 36 |
| succeed | you | 2.412887 | 30 |